Cited by 236RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryLipid Membrane Structure and Behavior

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Encapsulation state of messenger RNA inside lipid nanoparticles

Open access

Brader, Mark L., Williams, Sean J., Banks, Jessica M., Hui, Wong H., Zhou, Z. Hong, Jin, Lin·2021·Biophysical Journal

DOI 10.1016/j.bpj.2021.03.012PMC PMC8390897

Open this paper in CoChat — free account Open PDF

Abstract

Understanding the structure of messenger RNA (mRNA) lipid nanoparticles, and specifically the microenvironment of the mRNA molecules within these entities, is fundamental to advancing their biomedical potential. Here, we show that a permeating cationic dye, thionine, can serve as a cryogenic electron microscopy contrasting agent by binding selectively to encapsulated mRNA without disturbing lipid nanoparticle morphology. Cryo-electron microscopy images identify the mRNA location, revealing that mRNA may exist within solvent-filled cavities or may be substantially lipid associated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.bpj.2021.03.012

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Characterization of dye-binding and permeation. (a) Isothermal titration calorimetry of thionine titrated into mRNA. (Top) Raw data. (Bottom) Integrated heats of each injection versus molar ratio of thionine/nucleotide together with a fit using a one-site binding model. (b) Optical signatures of the thionine-mRNA binding interaction. Visible absorption spectra (top) of thionine at 0.0255 mM recorded in the absence of mRNA and in the presence of mRNA at low (4) and high (160) nucleotide/dye molar ratios (P/D). Corresponding circular dichroism (CD) spectra (bottom) show that at low P/D, the thionine absorption bands are resolved into negative and positive CD bands with extrema at 565 and 628 nm, respectively, whereas at high P/D, the induced CD is weak and characterized by a single positive band at 632 nm. (c) Dye permeation kinetics corresponding to mRNA-LNP added to a thionine solution. (Left) Scanning kinetics showing the spectral change as a function of time with scans taken at 2-min intervals. (Right) Kinetic time course of 600 nm absorbance together with a fit (red) to a first-order process with a rate constant of k = 0.143 min−1. (d) Nanoparticle tracking analysis of mRNA-LNP in the presence and absence of 0.5 mM thionine, showing small or insignificant effects of thionine on particle size and charge. Data represent the mean and error of 3 independent samples. (Left) Size distribution. (Right) ζ potential distribution.CC BY · PubMed Central

Figure 2 Visualizing free mRNA. Images show contrast enhancement using thionine of a 4000 nucleotide mRNA molecule. In the absence of dye (left), the resolution is comparable to published examples (25), whereas in the presence of 0.1 mM thionine (right), extended strand and molecular branching is more clearly discernible.CC BY · PubMed Central

Figure 3 Locating encapsulated mRNA in LNPs by cryo-EM. The effect of thionine on mRNA-LNPs of different morphologies reveals that lipid-dissociated mRNA may reside in bleb compartments (a) or may be more lipid-associated in spherical (b) or less prominently blebbed particles (c). The black arrow in (a) indicates the distinctive mottled mass density of mRNA inside the bleb cavity, which itself is distinguished by a thick, dark periphery. The blue arrow indicates the significant contrast enhancement that occurs when thionine dye is present, thereby identifying mRNA within the bleb. (d) Charge-driven migration of mRNA from the bleb into the body of the LNP. When the mRNA-LNP sample of (a) (no dye) was dialyzed into pH 5 buffer, the images of (d) resulted. The mottled density is now associated with the body of the LNP (green arrow), leaving the bleb cavity devoid of mRNA (white arrow). Addition of thionine to this sample produced no notable contrast change (right), indicating that thionine did not displace lipid.CC BY · PubMed Central

Figure 4 LNP physical degradation pathways. (a) Effects of physical stress on the LNP highlighted by dye. A dye-stained mRNA-LNP sample was subjected to multiple freeze-thaws. The resulting effects of this physical stress are evident, revealing aggregation (right), liberated mRNA (blue arrow), and the formation of liposomal structures containing mRNA (red arrow). The black arrow indicates an LNP that appears ready to burst. This image appears to capture a snapshot of how physical degradation leads to loss of mRNA encapsulation. (b) NTA size distribution profiles corresponding to the stressed and unstressed sample. Mean values with error bars are plotted. A cryo-EM image of the original unstressed LNP sample is provided as Data S2.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · cited 1×
“Intriguingly, mRNA-LNPs are known to form both spherical and highly nonspherical morphologies (9,11,16,18,19), but the origins and practical implications of these morphological variants”
Background
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Miao, L., Li, L., Huang, Y., Delcassian, D., Chahal, J., Han, J., Shi, Y., Sadtler, K., Gao, W., Lin, J., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0247-3 · Cited by 723 · cited 1×
“Intriguingly, mRNA-LNPs are known to form both spherical and highly nonspherical morphologies (9,11,16,18,19), but the origins and practical implications of these morphological variants”
Background
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719
On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA
Kulkarni, J. A., Darjuan, M. M., Mercer, J. E., Chen, S., van der Meel, R., Thewalt, J. L., Tam, Y. Y. C., & Cullis, P. R. (2018) · ACS Nano · doi:10.1021/acsnano.8b01516 · Cited by 663 · cited 1×
“In the case of LNPs containing short interfering RNA (siRNA), small angle xray scattering and cryo-electron microscopy (cryo-EM) data have been interpreted as evidence of a multilamellar structure in which the siRNA molecule is sandwiched between bilayer lipid assemblies (10,17).”
Background
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624 · cited 1×
“Lipid nanoparticles (LNPs) have emerged as the most promising nonviral delivery vehicle for exogenous mRNA (5,6).”
Background
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615
Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles
Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720542115 · Cited by 534
Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
Eygeris, Y., Patel, S., Jozić, A., & Sahay, G. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01386 · Cited by 397 · cited 1×
“It has been well established that LNPs with a diversity of morphological features can be generated through both manipulation of rapid precipitation conditions and formulation composition (10,15,26).”
Background
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389 · cited 1×
“Lipid nanoparticles (LNPs) have emerged as the most promising nonviral delivery vehicle for exogenous mRNA (5,6).”
Background
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
Leung, A. K. K., Tam, Y. Y. C., Chen, S., Hafez, I. M., & Cullis, P. R. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b02891 · Cited by 359 · cited 3×
“This interpretation differs from that of Leung and co-workers (11), who reported a strikingly similar cryo-EM image yet assigned the mRNA location to the body of the particle adjoined to the solvent-filled bleb.”
BackgroundResult
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260 · cited 1×
“Intriguingly, mRNA-LNPs are known to form both spherical and highly nonspherical morphologies (9,11,16,18,19), but the origins and practical implications of these morphological variants”
Background
Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy
Viger-Gravel, J., Schantz, A., Pinon, A. C., Rossini, A. J., Schantz, S., & Emsley, L. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b10795 · Cited by 202
Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers
Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187962 · Cited by 182 · cited 1×
“It has been well established that LNPs with a diversity of morphological features can be generated through both manipulation of rapid precipitation conditions and formulation composition (10,15,26).”
Background
Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads
Kulkarni, J. A., Witzigmann, D., Leung, J., van der Meel, R., Zaifman, J., Darjuan, M. M., Grisch-Chan, H. M., Thöny, B., Tam, Y. Y. C., & Cullis, P. R. (2019) · Nanoscale · doi:10.1039/c9nr02004g · Cited by 161 · cited 1×
“Intriguingly, mRNA-LNPs are known to form both spherical and highly nonspherical morphologies (9,11,16,18,19), but the origins and practical implications of these morphological variants”
Background
Visualizing large RNA molecules in solution.
Gopal, A., Zhou, H. Z., Knobler, C., & Gelbart, W. (2012) · RNA: A publication of the RNA Society · doi:10.1261/rna.027557.111 · Cited by 114 · cited 2×
“In the absence of dye (left), the resolution is comparable to published examples (25), whereas in the presence of 0.”
Background
Variations on Negative Stain Electron Microscopy Methods: Tools for Tackling Challenging Systems
Scarff, C. A., Fuller, M. J., Thompson, R. F., & Iadanza, M. G. (2018) · Journal of Visualized Experiments · doi:10.3791/57199 · Cited by 110 · cited 1×
“To overcome these limitations, we explored the concept of using an RNA-binding dye to stain LNPs in a somewhat analogous manner to classical cell staining with membrane-permeable dyes (21).”
Background
Mechanism of Macromolecular Structure Evolution in Self-Assembled Lipid Nanoparticles for siRNA Delivery
Gindy, M. E., DiFelice, K., Kumar, V., Prud’homme, R. K., Celano, R., Haas, R. M., Smith, J. S., & Boardman, D. (2014) · Langmuir · doi:10.1021/la500630h · Cited by 70 · cited 4×
“In the case of LNPs containing short interfering RNA (siRNA), small angle xray scattering and cryo-electron microscopy (cryo-EM) data have been interpreted as evidence of a multilamellar structure in which the siRNA molecule is sandwiched between bilayer lipid assemblies (10,17).”
BackgroundInfluential
In vitro-Transcribed mRNA Therapeutics: Out of the Shadows and Into the Spotlight
Karikó, K. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.009 · Cited by 57
Spectroscopic studies on the binding interaction of phenothiazinium dyes, azure A and azure B to double stranded RNA polynucleotides
Khan, A. Y., & Kumar, G. S. (2015) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2015.07.091 · Cited by 39
Variations on Negative Stain Electron Microscopy Methods: Tools for Tackling Challenging Systems
Scarff, C. A., Fuller, M. J., Thompson, R. F., & Iadanza, M. G. (2018) · Journal of Visualized Experiments · doi:10.3791/57199-v · Cited by 30
Toxic interaction of thionine to deoxyribonucleic acids: Elucidation of the sequence specificity of binding with polynucleotides
Paul, P., & Kumar, G. S. (2010) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2010.08.081 · Cited by 29 · cited 3×
“Intercalation and electrostatic (outside) Biophysical Letter Please cite this article in press as: Brader et al., Encapsulation state of messenger RNA inside lipid nanoparticles, Biophysical Journal (2021), https://doi.org/ 10.1016/j.bpj.2021.03.012 binding modes have been distinguished previously for phenothiazinium…”
BackgroundInfluential
Density based visualization for molecular simulation
Rozmanov, D. A., Baoukina, S., & Tieleman, D. P. (2014) · Faraday Discussions · doi:10.1039/c3fd00124e · Cited by 29 · cited 1×
“Molecular simulation studies (20) indicate that the LNP structure may involve solvent pockets, and experimental studies have shown nonspherical morphologies to be associated with segregation of the bilayer-forming 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) component, resulting in pronounced blebs (11).”
Background
Interaction of methylene blue with transfer RNA — a spectroscopic study
Antony, T., Atreyi, M., & Rao, M. V. R. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(95)03616-t · Cited by 22 · cited 1×
“1 b are consistent with the RNA/dye ratio-dependent signatures of these binding modes reported for transfer RNA (24).”
Background

Sorted by citations

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
“…is likely, as ionized dyes such as 2-(p-toluidino)-6-nap- thalene sulfonic acid (TNS) and thionine can enter the LNP core (Jayaraman et al., 2012; Brader et al., 2021) – the pH would be similar to the rest of the formulation, around 7 to 8, meaning that most of the ionizable cationic lipids…”
Influential
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Gregersen, C. H., Kulkarni, J. A., Witzigmann, D., Lind, M. L., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,271
“Recent studies have investigated LNP structure/lipid arrangement by using cryo-TEM [94,99,100], molecular dynamics (MD) [101], small-angle neutron scattering (SANS) [54], small-angle x-ray scattering (SAXS) [54,94], fluorescence microscopy [102], and NMR methods [103].”
Chemistry of Lipid Nanoparticles for RNA Delivery
Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00544 · Cited by 917
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Park, H., Otte, A., & Park, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.030 · Cited by 507
Payload distribution and capacity of mRNA lipid nanoparticles
Li, S., Hu, Y., Li, A. I., Lin, J., Hsieh, K., Schneiderman, Z., Zhang, P., Zhu, Y., Qiu, C., Kokkoli, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33157-4 · Cited by 299

See all 236

Authors: Brader, M. L., Williams, S. J., Banks, J. M., Hui, W. H., Zhou, Z. H., & Jin, L.
Affiliations: California NanoSystems Institute (US)
Corresponding author: Brader, Mark L.
ORCID: Brader, Mark L.
Williams, Sean J.
Zhou, Z. Hong
Jin, Lin
Venue: Biophysical Journal
Publisher: Elsevier BV
Published: 2021-07
Volume: 120
Issue: 14
Pages: 2766-2770
ISSN: 0006-3495 (ISSN-L)
DOI: 10.1016/j.bpj.2021.03.012
PMC: PMC8390897
OpenAlex: W3139111210
Cited by: 236
References: 27
Citations by year: 2026: 40 · 2025: 59 · 2024: 58 · 2023: 40 · 2022: 27 · 2021: 12
FWCI: 10.75
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Biophysical Journal (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, other-oa)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
Keywords: mRNA lipid nanoparticles, mRNA encapsulation, thionine, mRNA localization
MeSH terms: Lipids, RNA, Messenger, Cryoelectron Microscopy, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Encapsulation state of messenger RNA inside lipid nanoparticles

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks